Possible Implications of MCAM Expression in Metastasis and Non-Metastatic of Primary Uveal Melanoma Patients

2009 ◽  
Vol 34 (11) ◽  
pp. 1004-1009 ◽  
Author(s):  
Julia Beutel ◽  
Jürgen Wegner ◽  
Rayime Wegner ◽  
Focke Ziemssen ◽  
Khaled Nassar ◽  
...  
Keyword(s):  
Uveal Melanoma ◽  
Melanoma Patients

scholarly journals Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors

2021 ◽  
Vol 10 (8) ◽  
pp. 2618-2626
Author(s):  
Michael S. Sander ◽  
Igor Stukalin ◽  
Isabelle A. Vallerand ◽  
Siddhartha Goutam ◽  
Benjamin W. Ewanchuk ◽  
...  
Keyword(s):  
Uveal Melanoma ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitors ◽  
Checkpoint Inhibitors ◽  
Prognostic Index ◽  
Melanoma Patients

Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?

2000 ◽  
Vol 10 (1) ◽  
pp. 36-39 ◽  
Author(s):  
E. Tóth-Molnár ◽  
H. Hammer ◽  
J. Oláh
Keyword(s):  
Uveal Melanoma ◽  
Melanoma Patients

Genome-wide study on uveal melanoma patients finds association to DNA repair gene TDP1

2020 ◽  
Vol 30 (2) ◽  
pp. 166-172
Author(s):  
Hauke Thomsen ◽  
Subhayan Chattopadhyay ◽  
Per Hoffmann ◽  
Markus M. Nöthen ◽  
Helen Kalirai ◽  
...  
Keyword(s):  
Dna Repair ◽  
Uveal Melanoma ◽  
Repair Gene ◽  
Genome Wide ◽  
Dna Repair Gene ◽  
Melanoma Patients ◽  
Genome Wide Study

scholarly journals Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling

2020 ◽  
Vol 7 (1) ◽  
pp. 17-25 ◽  
Author(s):  
Amy C Schefler ◽  
Alison Skalet ◽  
Scott C N Oliver ◽  
John Mason ◽  
Anthony B Daniels ◽  
...  
Keyword(s):  
Gene Expression ◽  
Uveal Melanoma ◽  
Clinical Utility ◽  
Medical Oncology ◽  
Treatment Plan ◽  
Risk Class ◽  
Class 1 ◽  
Melanoma Patients ◽  
Metastatic Risk

Aim: The Clinical Application of DecisionDx-UM Gene Expression Assay Results study aimed to evaluate the clinical utility of the prognostic 15-gene expression profile (15-GEP) test for uveal melanoma (UM) patients in a large, prospective multicenter cohort. Patients & methods: Nine centers prospectively enrolled 138 UM patients clinically tested with the 15-GEP. Physician-recommended specialty referrals and metastatic surveillance regimens were collected. Results: A total of 93% of high-risk class 2 patients were referred to medical oncology for follow-up, compared with 51% of class 1 patients. A majority (62%) of class 2 patients were recommended overall high-intensity metastatic surveillance, while 85% of class 1 patients were recommended low-intensity metastatic surveillance. Conclusion: Treatment plan recommendations for UM patients are aligned with GEP-informed metastatic risk, consistent with prior studies.

scholarly journals Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients

2019 ◽  
Vol 60 (10) ◽  
pp. 3595 ◽  
Author(s):  
Wojtek Drabarek ◽  
Serdar Yavuzyigitoglu ◽  
Askar Obulkasim ◽  
Job van Riet ◽  
Kyra N. Smit ◽  
...  
Keyword(s):  
Uveal Melanoma ◽  
Survival Prediction ◽  
Melanoma Patients

Prognostication of metastatic death in uveal melanoma patients: A Markov multi-state model

2018 ◽  
Vol 102 ◽  
pp. 151-156 ◽  
Author(s):  
Antonio Eleuteri ◽  
Azzam F.G. Taktak ◽  
Sarah E. Coupland ◽  
Heinrich Heimann ◽  
Helen Kalirai ◽  
...  
Keyword(s):  
Uveal Melanoma ◽  
State Model ◽  
Melanoma Patients
Sign in / Sign up

Export Citation Format

Share Document